Gallstone Market Research Report 2024
Gallstone Market Global Industry Analysis And Forecast (2024- 2032) By Cause (Cholesterol Stone, Bilirubin, Concentrated Bile, and Others), By Diagnosis (Ultrasound, Abdominal CT Scan, Gallbladder Radionuclide Scan, Blood Tests, and Others), By Treatment (Open Cholecystectomy, Laparoscopic Cholecystectomy, Medications, and Others), And by Region
Gallstone Market Synopsis
Gallstone Market was worth USD 0.35 Billion in 2023. As such, the forecast is that the market is expected to reach USD 0.7 Billion by 2032 with a CAGR of 8.06 % from 2024 to 2032.
The gallstone market refers to the industry involved in the diagnosis, treatment, and management of gallstones, which are hardened deposits of digestive fluid that can form in the gallbladder. The market encompasses a range of medical products and services, including imaging technologies, surgical procedures, and pharmaceutical treatments designed to address gallstone-related conditions.
The gallstone market has been experiencing steady growth due to the increasing prevalence of gallstone-related diseases. Factors such as rising obesity rates, sedentary lifestyles, and high-fat diets contribute to the higher incidence of gallstones. Additionally, advancements in diagnostic technologies and minimally invasive surgical techniques are boosting market demand.Technological innovations in imaging and diagnostic tools, such as ultrasound and endoscopic methods, have improved early detection and treatment of gallstones. This has led to more effective and less invasive management options, further driving market expansion.The pharmaceutical sector also plays a critical role in the market, offering medications to dissolve gallstones or manage symptoms. This sector is evolving with the development of new drugs and combination therapies aimed at improving patient outcomes.
Top Key Players Involved Are:
"Boston Scientific (USA), Medtronic (USA), Johnson & Johnson (USA), Stryker Corporation (USA), Becton Dickinson (USA), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), GE Healthcare (USA), Fujifilm Holdings Corporation (Japan), Canon Medical Systems (Japan), Hologic, Inc. (USA), Bracco Diagnostics Inc. (USA), Ethicon Inc. (USA), Alcon Laboratories, Inc. (Switzerland), Cook Medical (USA), Guerbet Group (France), Hansen Medical (USA), Karl Storz (Germany), Olympus Corporation (Japan), Smith & Nephew (UK), Aesculap, Inc. (Germany), Zimmer Biomet (USA), Coloplast (Denmark), Medline Industries, Inc. (USA), Integra LifeSciences (USA), Terumo Corporation (Japan), and Other Active Players."
Gallstone Market Trend Analysis
Growing Frequency Of Gallstone Disease:
- The increasing prevalence of gallstone disease is a key driver of growth in the gallstone market. Several factors contribute to this trend, including an aging population, which is more susceptible to gallstones, and the rising incidence of the condition itself. The market is also bolstered by the growing demand for elective laparoscopic procedures, which offer minimally invasive options for treating gallstones. Enhanced awareness and early diagnosis of gallstone disease further support market expansion, as individuals are more likely to seek timely medical intervention.
- Additionally, conditions such as liver cirrhosis, chronic hepatitis C virus infections, obesity, metabolic syndrome, diabetes mellitus, dyslipidemia, and non-alcoholic fatty liver disease are known to increase the risk of gallstone formation. Poor dietary habits and sedentary lifestyles also contribute to the growing prevalence of gallstones. As these health challenges become more common, they are expected to drive the demand for effective treatment options, thereby propelling the gallstone market forward throughout the forecast period.
Growing Healthcare Awareness in Emerging Markets:
- Growing healthcare awareness in emerging markets presents a significant opportunity for the gallstone market. As awareness about gallstone diseases increases, there is a rising demand for both diagnostic and therapeutic solutions.
- Emerging economies are experiencing improved healthcare infrastructure, which is facilitating better access to diagnostic tools and treatments for gallstones. With governments and private sectors investing in healthcare, these regions are seeing advancements in medical technology and increased availability of treatment options.
- The rising middle class in these regions is also contributing to higher healthcare spending. As disposable incomes rise, more individuals can afford healthcare services, including those for managing gallstones. This growing market segment is driving demand for both preventive and curative solutions.
- Educational initiatives and awareness campaigns about gallstone prevention and management are likely to increase patient engagement and early diagnosis. This trend creates opportunities for market players to expand their presence and cater to the growing needs of these regions.
Gallstone Market Segment Analysis:
The Global Gallstone Market is Segmented into Cause, Diagnosis, treatment, and Region.
By Cause, the Cholesterol stones segment is expected to dominate the market during the forecast period.
- the cholesterol stones segment emerged as the dominant force in the gallstone market. This dominance is primarily attributed to the high prevalence of gallbladder inflammation, a condition commonly associated with cholesterol stones. Cholesterol stones, which are a type of gallstone, significantly contribute to cholecystitis, an inflammatory condition of the gallbladder. The impact of this segment is underscored by the substantial incidence rates of acute cholecystitis.
- Globally, the rate of acute cholecystitis stands at approximately 6,300 cases per 100,000 individuals under the age of 50, and a striking 20,900 cases per 100,000 individuals over the age of 50. These statistics highlight the widespread nature of the condition and its strong influence on the gallstone market. Consequently, the cholesterol stones segment's prevalence and impact have played a crucial role in its market dominance, reflecting both the high incidence of cholecystitis and the significant demand for treatments targeting cholesterol stones.
By Treatment, the Laparoscopic cholecystectomy segment held the largest share in 2023.
- The laparoscopic cholecystectomy segment has emerged as the dominant force in the gallstone market, driven by its numerous advantages over traditional methods. This minimally invasive procedure, typically completed within one to two hours, involves inserting a small video camera through a tiny abdominal incision. Its growing popularity is attributed to several key benefits, including shorter hospital stays, reduced blood loss, and lower patient morbidity. The procedure’s minimal incision, rapid recovery, quick and successful outcomes, reduced risk of infection, and less pain contribute to its high demand.
- As a result, the market for cholecystectomy equipment is expected to experience robust growth throughout the forecast period. In contrast, open cholecystectomy, a traditional surgical approach, is reserved for cases where laparoscopic methods are not feasible. This segment has seen slower growth and holds a smaller market share due to factors such as recent technological advancements, increased preference for minimally invasive procedures, longer postoperative recovery, and higher risks of complications like severe bleeding and common bile duct injuries.
Gallstone Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast Period
- North America commanded a dominant share of the gallstone market. This significant market presence is primarily driven by the region’s strong preference for laparoscopic cholecystectomy over traditional open cholecystectomy procedures. Laparoscopic methods, which are favored for their minimally invasive nature, facilitate quicker recovery times and better patient outcomes compared to conventional approaches. This shift towards less invasive procedures is a key factor propelling market growth in North America.
- The intense competition among major market players for product innovation is bolstering the region’s market position. The U.S., in particular, is experiencing escalating healthcare costs, which could lead to an influx of both new and existing competitors striving to capture market share. The combined effects of advanced surgical techniques and a competitive industry landscape are reinforcing North America's leading role in the gallstone market.
Gallstone Market Top Key Players:
- Boston Scientific (USA)
- Medtronic (USA)
- Johnson & Johnson (USA)
- Stryker Corporation (USA)
- Becton Dickinson (USA)
- Siemens Healthineers (Germany)
- Philips Healthcare (Netherlands)
- GE Healthcare (USA)
- Fujifilm Holdings Corporation (Japan)
- Canon Medical Systems (Japan)
- Hologic, Inc. (USA)
- Bracco Diagnostics Inc. (USA)
- Ethicon Inc. (USA)
- Alcon Laboratories, Inc. (Switzerland)
- Cook Medical (USA)
- Guerbet Group (France)
- Hansen Medical (USA)
- Karl Storz (Germany)
- Olympus Corporation (Japan)
- Smith & Nephew (UK)
- Aesculap, Inc. (Germany)
- Zimmer Biomet (USA)
- Coloplast (Denmark)
- Medline Industries, Inc. (USA)
- Integra LifeSciences (USA)
- Terumo Corporation (Japan), and Other Active Players.
Key Industry Development:
- In January 2024, Boston Scientific Corporation announced it had entered into a definitive agreement to acquire Axonics, Inc., a publicly traded medical technology firm specializing in devices for urinary and bowel dysfunction. The acquisition, valued at $71 per share, totaled approximately $3.7 billion in equity and $3.4 billion in enterprise value. This strategic move was aimed at enhancing Boston Scientific’s portfolio and capabilities in the field of medical technology. The transaction was expected to bolster the company's presence in the treatment of urinary and bowel disorders through Axonics' innovative solutions.
- In September 2023, Boston Scientific Corporation announced it had entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company. This acquisition aimed to enhance Boston Scientific’s portfolio in the field of pain management. Relievant Medsystems is renowned for its innovative treatment solutions for chronic pain, and the acquisition is expected to bolster Boston Scientific's capabilities and market position in this sector. The deal underscores Boston Scientific’s commitment to expanding its therapeutic offerings and advancing patient care through cutting-edge technologies. The transaction details and timeline for completion were not immediately disclosed.
|
Global Gallstone Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024- 2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 0.35 Bn. |
|
Forecast Period 2024-32 CAGR: |
8.06 % |
Market Size in 2032: |
USD 0.7 Bn. |
|
Segments Covered: |
By Cause |
|
|
|
By Diagnosis |
|
||
|
By Treatment |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Gallstone Market by Cause
4.1 Gallstone Market Snapshot and Growth Engine
4.2 Gallstone Market Overview
4.3 Cholesterol Stone
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD
Frequently Asked Questions
What would be the forecast period in the Global Gallstone Market research report?
The forecast period in the Global Gallstone Market research report is 2024- 2032.
Who are the key players in the Global Gallstone Market?
Boston Scientific (USA), Medtronic (USA), Johnson & Johnson (USA), Stryker Corporation (USA), Becton Dickinson (USA), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), GE Healthcare (USA), Fujifilm Holdings Corporation (Japan), Canon Medical Systems (Japan), Hologic, Inc. (USA), Bracco Diagnostics Inc. (USA), Ethicon Inc. (USA), Alcon Laboratories, Inc. (Switzerland), Cook Medical (USA), Guerbet Group (France), Hansen Medical (USA), Karl Storz (Germany), Olympus Corporation (Japan), Smith & Nephew (UK), Aesculap, Inc. (Germany), Zimmer Biomet (USA), Coloplast (Denmark), Medline Industries, Inc. (USA), Integra LifeSciences (USA), Terumo Corporation (Japan), and Other Active Players.
What are the segments of the Global Gallstone Market?
The Gallstone Market is Segmented into Cause, Diagnosis, treatment, and Region. By Cause, the market is categorized into (Cholesterol Stone, Bilirubin, Concentrated Bile, and Others), and Services), By Diagnosis, the market is categorized into ((Ultrasound, Abdominal CT Scan, Gallbladder Radionuclide Scan, Blood Tests, and Others). By Treatment, the market is categorized into (Open Cholecystectomy, Laparoscopic Cholecystectomy, Medications, and Others). By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
What is the Global Gallstone Market?
The gallstone market refers to the industry involved in the diagnosis, treatment, and management of gallstones, which are hardened deposits of digestive fluid that can form in the gallbladder. The market encompasses a range of medical products and services, including imaging technologies, surgical procedures, and pharmaceutical treatments designed to address gallstone-related conditions.
How big is the Global Gallstone Market?
The Global Gallstone Market was worth USD 0.35 Billion in 2023. As such, the forecast is that the market is expected to reach USD 0.7 Billion by 2032 with a CAGR of 8.06 % from 2024 to 2032.
